Table 3.
Study clinical outcome measurements by time point
Outcome measure | Time point |
---|---|
Person with dementia | |
Sociodemographics | Initial screen |
MMSE [56] | Initial screen |
GDS-12R [57] | Initial screen, post-treatment follow-up |
CSDD [76] | Baseline, post-treatment follow-up |
DEMQOL [81] | Baseline, post-treatment follow-up |
EQ-5D-3L [82] | Baseline, post-treatment follow-up |
Informal carer | |
Sociodemographics | Initial screen |
PHQ-9 [84] | Initial screen, post-treatment follow-up |
GAD-7 [85] | Baseline, post-treatment follow-up |
ZBI-12 [86] | Baseline, post-treatment follow-up |
CSDD-proxy [76] | Baseline, post-treatment follow-up |
SF-12 [87] | Baseline, post-treatment follow-up |
EQ-5D-3L [83] | Baseline, post-treatment follow-up |
Revised CSRI [88] | Baseline, post-treatment follow-up |
MMSE mini-mental state examination, GDS-12R Geriatric Depression Scale-12 Residential, CSDD Cornell Scale for Depression in Dementia, DEMQOL Dementia Quality of Life Measure, EQ-5D-3L EuroQol-5D-3L, PHQ-9, Health Questionnaire-9, GAD-7 Generalised Anxiety Disorder 7-Item Scale, ZBI-12 Zarit Caregiver Burden Interview Short Form, SF-12 12-Item Short Form Health Survey, CSRI Client Service Receipt Inventory